Market Overview

Clinical Innovations hires Richard Ji as vice president of operations

Share:

Clinical
Innovations
, one of the world's leading medical device-makers
focused on labor and delivery and neonatal intensive care, today
announced the hiring of Richard Ji as its new vice president of
operations.

Ji, who has more than two decades of operations leadership experience in
the medical device industry, will be responsible for strengthening and
streamlining operations throughout the Clinical Innovations
organization. He was most recently the vice president of catheter
solutions for global medical technology company Becton Dickinson.

"Richard's industry experience and track record of leading teams to
tremendous results make him ideally suited to leading Clinical
Innovations' operations as we continue to build and grow," said Ken
Reali, CEO and president. "We're thrilled to have him on-board and look
forward to the positive impact he'll bring to all aspects of our
business."

An alumnus of Brigham Young University with an MBA from Duke
University's Fuqua School of Business, Ji joined Becton Dickinson in
1995 and quickly advanced through the company's ranks in roles
overseeing manufacturing, research, quality and supply chain. Noted for
driving growth and efficiency, Ji held positions throughout the U.S. and
overseas and, in his most recent role, oversaw an $800 million business
with more than 1,200 employees.

"Clinical Innovations is a strong organization with a smart growth
strategy and the results to show for it," said Ji. "I'm honored to join
such a talented team and look forward to accelerating those gains."

Clinical Innovations develops and manufactures medical devices used
before, during and after delivery to ensure optimal health outcomes for
mothers and babies. The company, whose market-leading products are used
in more than 90 countries, has been expanding domestically and
internationally, acquiring Australian distributor JB Medical Supplies in
June and German company Brenner Medical GmbH in summer 2017.

The Salt Lake City company, which is celebrating its quarter-century
anniversary throughout 2018, is owned by EQT, a leading investment firm
with approximately EUR 50 billion in raised capital across 27 funds.

About Clinical Innovations

Clinical Innovations is one of the largest medical device companies
exclusively focused on labor and delivery and neonatal intensive care.
The company is a market-leader in several categories with products such
as the Koala® Intrauterine Pressure Catheter, Kiwi® Vacuum-Assisted
Delivery System, ROM Plus® Rupture of Membranes Test, traxi® Panniculus
Retractor, ClearView® Uterine Manipulator, the babyLance™ Safety heel
stick and the ebb® Complete Tamponade System. Clinical Innovations is
expanding its global presence while directly researching and developing
state-of-the-art technologies and innovative medical devices that
fulfill its mission of improving the lives of mothers and their babies
throughout the world. Clinical Innovations is an EQT portfolio company.
For more information, visit clinicalinnovations.com.

About EQT

EQT is a leading investment firm with approximately EUR 50 billion in
raised capital across 27 funds. EQT funds have portfolio companies in
Europe, Asia and the U.S. with total sales of more than EUR 19 billion
and approximately 110,000 employees. EQT is an active investor and owner
in the health care sector, including investments in Certara, Press
Ganey, Ottobock, Sivantos, and Lima. EQT works with portfolio companies
to achieve sustainable growth, operational excellence and market
leadership. For more information, visit EQTpartners.com.

View Comments and Join the Discussion!